高血压患者短期血压变异性与新发慢性肾脏病:心血管与代谢疾病病因研究中心-高危(CMERC-HI)研究结果
该前瞻性观察队列研究纳入1173例估算肾小球滤过率≥60mL/min/1.73m2的高血压患者,评估短期血压变异性(以平均真实变异性ARV衡量)与复合肾脏病结局的关联。中位随访5.4年期间发生271例复合肾脏病结局事件,多变量Cox分析显示最高三分位收缩压ARV和舒张压ARV与最低三分位相比复合肾脏病结局风险更高,独立于24小时血压水平。
要点
- 最高三分位收缩压ARV与最低三分位相比,复合肾脏病结局风险更高(HR 1.64,95%CI 1.16-2.33)。
- 最高三分位舒张压ARV与最低三分位相比,复合肾脏病结局风险更高(HR 1.60,95%CI 1.15-2.24)。
- 短期血压变异性的其他指标(标准差、变异系数、昼夜节律模式)与复合肾脏病结局无显著关联。
核心结论
- 在高血压患者中,短期血压变异性与复合肾脏病结局的发生相关。
研究设计与样本
- 前瞻性观察队列研究,纳入心血管与代谢疾病病因研究中心-高危(CMERC-HI)研究(2013-2018年)中1173例估算肾小球滤过率≥60mL/min/1.73m2的高血压参与者。
- 暴露为通过平均真实变异性(ARV)评估的短期血压变异性。
- 采用多变量Cox回归分析评估收缩压ARV和舒张压ARV与结局的关联。
主要发现
- 中位随访5.4年(四分位间距4.1-6.5年)期间,共发生271例复合肾脏病结局事件(46.5/1000人年)。
- 多变量Cox分析显示,最高三分位收缩压ARV与最低三分位相比,复合肾脏病结局风险更高(HR 1.64,95%CI 1.16-2.33),独立于24小时收缩压水平。
- 最高三分位舒张压ARV与最低三分位相比,复合肾脏病结局风险更高(HR 1.60,95%CI 1.15-2.24),独立于24小时舒张压水平。
- 将收缩压ARV和舒张压ARV作为连续变量分析时,关联一致:收缩压ARV每增加1.0单位,HR 1.03(95%CI 1.01-1.06);舒张压ARV每增加1.0单位,HR 1.04(95%CI 1.01-1.08)。
- 这些关联在各个亚组(年龄、性别、24小时收缩压或舒张压、中度白蛋白尿)中一致;然而,短期血压变异性的其他指标包括标准差、变异系数和昼夜节律模式与复合肾脏病结局无显著关联。
局限性
- 观察性研究设计。
- 使用单次24小时血压测量。
- 缺乏随访期间抗高血压药物变化的信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: The association between short-term blood pressure variability (BPV) and kidney outcomes is poorly understood. This study evaluated the association between short-term BPV and kidney disease outcomes in people with hypertension. STUDY DESIGN: Prospective observational cohort study. SETTING & PARTICIPANTS: 1,173 hypertensive participants in the Cardiovascular and Metabolic Disease Etiology Research Center-High Risk (2013-2018) Study with estimated glomerular filtration rate (eGFR) ≥60mL/min/1.73m2. EXPOSURE: Short-term BPV assessed by average real variability (ARV). OUTCOME: Composite kidney disease outcome (30% decline in eGFR from baseline, new occurrence of eGFR <60mL/min/1.73m2, or onset of UACR >300mg/g). ANALYTICAL APPROACH: Multivariable Cox regression analyses to evaluate the association between systolic and diastolic BP ARV (SBP-ARV and DBP-ARV) and outcomes. RESULTS: During a median follow-up of 5.4 [4.1-6.5] years, 271 events of the composite kidney disease outcome occurred (46.5 per 1,000 person-years). Multivariable Cox analysis revealed that the highest SBP-ARV and DBP-ARV tertiles were associated with a higher risk of the composite kidney disease outcome than the lowest tertiles, independent of the 24-hour SBP or DBP levels (HR, 1.64 [95% CI, 1.16-2.33], and 1.60 [95% CI, 1.15-2.24] for SBP-ARV and DBP-ARV, respectively). These associations were consistent when SBP-ARV and DBP-ARV were treated as continuous variables (HR per 1.0-unit greater SBP-ARV, 1.03 [95% CI, 1.01-1.06]; HR per 1.0-unit greater DBP-ARV, 1.04 [95% CI, 1.01-1.08]). These associations were consistent, irrespective of subgroups (age, sex, 24-hour SBP or DBP, and moderate albuminuria). However, other measures of short-term BPV including SD, coefficient of variation, and dipping patterns were not associated with the composite kidney disease outcome. LIMITATIONS: Observational study design, the use of single measurement of 24-hour BP, lack of information on changes in antihypertensive medication during the follow-up. CONCLUSIONS: Short-term BPV is associated with the development of a composite kidney disease outcome in hypertensive patients.
引用
- Jhee JH, Oh D, Seo J, et al. Short-term Blood Pressure Variability and Incident CKD in Patients With Hypertension: Findings From the Cardiovascular and Metabolic Disease Etiology Research Center-High Risk (CMERC-HI) Study. Am J Kidney Dis. 2022. PMID: 36241008. doi:10.1053/j.ajkd.2022.08.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。